NV Las Vegas의 제2형 당뇨병 임상 시험
제2형 당뇨병 관련 연구 17개가 Las Vegas 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
피험자 모집 중3상
- Palm Research Center, Las Vegas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
피험자 모집 중3상
- Las Vegas Clinical Trials, Las Vegas
- AB Clinical Trials, Las Vegas
- Palm Research Center, Las Vegas
- 외 2개
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
피험자 모집 중3상
- Research Site, Las Vegas
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
피험자 모집 중2상
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
피험자 모집 중2상
- DaVita Clinical Research, Las Vegas
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
피험자 모집 중3상
- Research Site, Las Vegas
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
피험자 모집 중2상
- Excel Clinical Research, Las Vegas
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
피험자 모집 중2상
- Santa Rosa Medical Centers of Nevada, Las Vegas
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
피험자 모집 중2상
- Alliance Clinical - Las Vegas, Las Vegas
- Palm Research Center, Inc., Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
피험자 모집 중3상
- Palm Research Center Inc, Las Vegas
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
피험자 모집 중3상
- Palm Research Center Inc-Vegas, Las Vegas
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
피험자 모집 중건강한 지원자 환영
- Southwest Medical Associates- Optum Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
피험자 모집 중3상
- AURORA-2 Clinical Site, Las Vegas
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
피험자 모집 중3상
- Research Site, Las Vegas
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
피험자 모집 중3상
- Palm Research Center Inc-Vegas, Las Vegas
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
피험자 모집 중3상
- Research Site, Las Vegas
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
피험자 모집 중2상
- Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas
다른 도시의 제2형 당뇨병 시험
- San Antonio, TX연구 37개
- Houston, TX연구 31개
- Orlando, FL연구 25개
- Atlanta, GA연구 21개
- San Diego, CA연구 21개
- Boston, MA연구 20개
- Miami, FL연구 20개
- Chicago, IL연구 19개
- Arlington, VA연구 19개
- Los Angeles, CA연구 18개
- Dallas, TX연구 18개
- Columbus, OH연구 17개
Las Vegas의 다른 연구
- 비만연구 21개
- 과체중연구 19개
- 주요우울장애연구 13개
- 유방암연구 11개
- 비소세포폐암연구 10개
- 암 (전체)연구 9개
- 전이성 암연구 8개
- 대장직장암연구 8개
- 조현병연구 7개
- 전립선암연구 7개
- 알츠하이머병연구 7개
- 크론병연구 7개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.